Potential anticancer agents. 16. Methotrexate analogues with a modified peptide side chain

Area of Science:

• Medicinal Chemistry
• Pharmacology
• Organic Synthesis

Background:

• Methotrexate is a crucial chemotherapy agent.
• Modifying drug structures can alter efficacy and reduce side effects.
• The glutamyl moiety of methotrexate is essential for its activity.

Purpose of the Study:

• To synthesize novel methotrexate analogues.
• To investigate the impact of replacing the glutamyl moiety with other amino acids.
• To evaluate the anticancer activity of these analogues against L1210 leukemia.

Main Methods:

• Synthesis of nine methotrexate analogues using 2,4-diamino-6-(chloromethyl)pteridine.
• Modification involved replacing the terminal glutamyl group with various amino acids.
• Anticancer activity was assessed using the L1210 cell line.

Main Results:

• All nine synthesized analogues were characterized.
• None of the modified compounds demonstrated significant cytotoxic or inhibitory activity against L1210 cells.
• The replacement of the glutamyl moiety appears to abolish anticancer efficacy.

Conclusions:

• The terminal glutamyl moiety is critical for the biological activity of methotrexate.
• Further research is needed to identify other structural modifications that retain or enhance anticancer properties.
• These findings provide insights into structure-activity relationships for antifolate drugs.